Renu MedTech

Mission: Use deep tech to democratize advanced diabetes care in India and other low / middle income countries (LMICs), through cutting-edge and affordable medical devices Problem: India has 140 mn+ diabetics, 5% of which are Type 1 with a high mortality rate of 33%. LMICs rely on insulin injections which are painful and have a huge risk of potentially fatal glycemic fluctuation. Medically, the best line of treatment for diabetics is "an insulin infusion pump coupled with a glucose monitor", which is well established in the US and EU. However, in India - This technology is prohibitively unaffordable - Neither is it designed for India / other LMICs and local conditions - Nor does insurance cover this technology unlike the developed economies Solution: Use deep tech to disrupt this market with "An insulin infusion pump and a glucose monitor", that are Made in India, for the global market - Target Price point: 1/10th of current - Markets: India, followed by SE Asia, South Asia, Africa, followed by US, EU, ANZ - Users - Insulin Pump: Type 1 and insulin dependent Type 2 diabetics - CGM: Type 1 and Type 2 diabetics, Wellness users India needs a Maruti Suzuki and not a Mercedes!

• Employees3